Squarepoint’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.9K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $56.6K | Buy |
|
|||||
|
2024
Q3 | $47.2K | Sell |
|
|||||
|
2024
Q2 | $422K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $660K | Sell |
|
|||||
|
2023
Q3 | $583K | Buy |
|
|||||
|
2023
Q2 | $306K | Sell |
|
|||||
|
2023
Q1 | $708K | Sell |
|
|||||
|
2022
Q4 | $6.01M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $327K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $5.8M | Buy |
|
|||||
|
2021
Q2 | $560K | Sell |
|
|||||
|
2021
Q1 | $1.26M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $502K | Sell |
|
|||||
|
2020
Q2 | $2.28M | Buy |
|
|||||
|
2020
Q1 | $302K | Sell |
|
|||||
|
2019
Q4 | $1.25M | Sell |
|
|||||
|
2019
Q3 | $2.6M | Buy |
|
|||||
|
2019
Q2 | $695K | Sell |
|
|||||
|
2019
Q1 | $1.47M | Buy |
|
|||||
|
2018
Q4 | $253K | Sell |
|
|||||
|
2018
Q3 | $905K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $70K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $94K | Hold |
|
|||||
|
2017
Q1 | $131K | Buy |
|
|||||
|
2016
Q4 | $50K | Buy |
|